Neuburgh Advisers’s Gilead Sciences GILD Stock Holding History

Neuburgh Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6.8M	Buy	107,360 +22,848	+27%	+$1.49M	0.21%	96
2019 Q2	$5.71M	Buy	84,512 +15,360	+22%	+$1.01M	0.18%	113
2019 Q1	$4.5M	Buy	69,152 +5,232	+8%	+$348K	0.15%	128
2018 Q4	$4M	Sell	63,920 -2,624	-4%	-$183K	0.16%	130
2018 Q3	$5.14M	Sell	66,544 -160,800	-71%	-$12.1M	0.17%	127
2018 Q2	$16.1M	Sell	227,344 -1,904	-0.8%	-$134K	0.54%	46
2018 Q1	$17.3M	Buy	229,248 +51,328	+29%	+$4.08M	0.6%	44
2017 Q4	$12.7M	Sell	177,920 -4,144	-2%	-$315K	0.46%	56
2017 Q3	$14.8M	Sell	182,064 -19,632	-10%	-$1.5M	0.55%	47
2017 Q2	$14.3M	Sell	201,696 -84,160	-29%	-$5.6M	0.54%	48
2017 Q1	$19.4M	Sell	285,856 -219,648	-43%	-$15.4M	0.77%	34
2016 Q4	$36.2M	Buy	+505,504	New	+$37.6M	1.63%	12

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Neuburgh Advisers's GILD Position: Q3 2019 in Review

Neuburgh Advisers increased its Gilead Sciences (GILD) stake by 27% in Q3 2019, buying an estimated $1.49M and bringing the position to 107,360 shares worth $6.8M. The position accounts for 0.21% of the portfolio, ranked #96.

Neuburgh Advisers first reported a position in GILD in Q4 2016 and has held it in 12 quarters since. The position peaked at $36.2M in Q4 2016. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Neuburgh Advisers held 107,360 shares of Gilead Sciences worth $6.8M as of Q3 2019.
Neuburgh Advisers bought 22,848 Gilead Sciences shares in Q3 2019, an estimated $1.49M.
Gilead Sciences made up 0.21% of Neuburgh Advisers's portfolio in Q3 2019, its #96 holding.
Neuburgh Advisers first reported a position in Gilead Sciences in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Gilead Sciences position peaked at $36.2M in Q4 2016.
1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.